Research-Grade Pharmaceutical Overview
Vigora 100mg represents a pharmaceutical-grade sildenafil citrate preparation designed specifically for controlled laboratory investigations. Sildenafil citrate is a phosphodiesterase type-5 (PDE5) inhibitor originally developed for cardiovascular research applications. This compound selectively inhibits the PDE5 enzyme, which hydrolyses cyclic guanosine monophosphate (cGMP) in vascular smooth muscle cells. Each tablet contains 100mg of active sildenafil citrate in pharmaceutical formulation, providing consistent potency for research protocols requiring standardised dosing references.
Laboratory researchers investigating cardiovascular mechanisms often examine sildenafil’s effects on nitric oxide signalling pathways. The compound’s mechanism involves competitive inhibition of PDE5, resulting in increased intracellular cGMP levels in experimental tissue models. This pharmaceutical preparation offers researchers access to precisely formulated material matching clinical-grade specifications used in published cardiovascular studies. Stroid UK Shop maintains strict quality standards for all pharmaceutical research compounds.
Laboratory Research Applications
Scientific investigations examining PDE5 inhibition mechanisms utilise sildenafil citrate across multiple research disciplines. Cardiovascular researchers study the compound’s effects on vascular reactivity in isolated vessel preparations and cell culture models. Pulmonary arterial hypertension research protocols examine sildenafil’s vasodilatory properties in experimental lung tissue studies. Neurological research applications investigate the compound’s potential neuroprotective effects through cGMP-dependent signalling cascades.
Molecular biology laboratories analyse sildenafil’s interaction with PDE5 enzyme kinetics using biochemical assays and protein binding studies. Pharmacokinetic research protocols examine absorption, distribution, and metabolism patterns in controlled laboratory environments. Research teams studying sildenafil citrate preparations often compare different formulations for bioavailability characteristics. Additionally, comparative studies with other research compounds from selective androgen receptor modulators and bioactive peptides provide comprehensive pharmacological research data.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Concentration | 100mg per tablet |
| Formulation | Pharmaceutical tablet |
| CAS Number | 171599-83-0 (sildenafil citrate) |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Pharmaceutical standard |
Research Compliance Statement
Vigora 100mg pharmaceutical sildenafil citrate is supplied exclusively for in-vitro laboratory research applications and analytical studies. This product is not approved for human consumption, therapeutic use, or any form of in-vivo application. Researchers must maintain appropriate laboratory safety protocols and institutional oversight when handling this research material. All studies should comply with relevant research ethics guidelines and institutional review board requirements. This pharmaceutical preparation is intended solely for qualified research institutions and licensed laboratory facilities conducting legitimate scientific investigations into phosphodiesterase inhibition mechanisms and related cardiovascular research applications.
